Printer Friendly
The Free Library
14,716,402 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Windber Research Institute Establishes State-of-the-Art Research Organization Using Amersham Biosciences Technology.


Business & Science Editors/Health & Medical Writers

PISCATAWAY, N.J.--(BW HealthWire)--Dec. 19, 2001

Scientists to develop national tissue repository to identify

and characterize genetic alterations in high risk

and breast cancer patients

Amersham Biosciences today announced that it has provided the Windber Research Institute This articlearticle or section has multiple issues:
* It needs sources or references that appear in third-party publications.
* It reads like an advertisement and needs to be rewritten in a neutral point of view.
 with cutting-edge technology that will form the core of the state-of-the-art biotechnology research facility. The Institute will use the technology to undertake its critical initiatives in the fight against cancer.

The instrumentation, chemistry and software tools provided will facilitate the identification of disease-related genes. The applications covered by this product portfolio included genomics - DNA sequencing, microarrays and genotyping - and proteomics - 2D gel electrophoresis, spot picking, digestion and mass spectrometry mass spectrometry
 or mass spectroscopy

Analytic technique by which chemical substances are identified by sorting gaseous ions by mass using electric and magnetic fields.
. These technologies will allow scientists at the Windber Research Institute to look below the surface and into the cell to discover the location and function of genes and proteins associated with cancer, and to determine when and how these genes and proteins function.

"We are very pleased that Amersham Biosciences has provided the Windber Research Institute with the technologies needed to significantly strengthen our research and discovery initiatives," said F. Nicholas Jacobs, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of the Windber Research Institute. "The Institute is committed to discovering potential molecular causes of cancer, and Amersham Biosciences is critical to that commitment."

The Windber Research Institute, which had its grand opening on October 11, is undertaking a number of initiatives dedicated to the identification of disease-related genes. One of the Institutes major activities is a collaboration with the Clinical Breast Care Project of Walter Reed Army Medical Center Walter Reed Army Medical Center, major hospital complex in Washington, D. C., and Forest Glen, Md.; est. 1923 and named for U.S. army surgeon Walter Reed. It is composed of seven units including a general hospital and a research institute. There are several thousand beds. , headed by Lt Col Craig Shriver shrive  
v. shrove or shrived, shriv·en or shrived, shriv·ing, shrives

v.tr.
1. To hear the confession of and give absolution to (a penitent).

2.
, MD, the Joyce Murtha Breast Care Center, and the Conemaugh Health System to develop a national breast tissue repository. Additional initiatives include a bioimaging Center and the characterization of the gene and protein expression profile of breast cancer patients, high-risk patients with no clinical symptoms, patients undergoing chemotherapy and vaccination and/or adjuvant therapy Adjuvant therapy
A treatment done when there is no evidence of residual cancer in order to aid the primary treatment. Adjuvant treatments for endometrial cancer are radiation therapy, chemotherapy, and hormone therapy.
 said, Dr Richard Somiari, the Scientific Director. According to Dr Henry Brzeski, the Executive Director, the Institute also boasts partnerships with over twenty-five universities, leading publicly held corporations and institutions, research foundations and military medical facilities.

"As Amersham Biosciences' technology spans the entire process from determining the function of genes and proteins to drug discovery and development, we are able to provide the Windber Research Institute with the necessary means to further the prestigious research being conducted," said Peter Coggins, Vice President of Sales for Amersham Biosciences. "It is very gratifying grat·i·fy  
tr.v. grat·i·fied, grat·i·fy·ing, grat·i·fies
1. To please or satisfy: His achievement gratified his father. See Synonyms at please.

2.
 to be a part of such an important institution, and to be a significant component in the Institute's efforts." The Windber Research Institute will now serve as a comprehensive demonstration site for Amersham Biosciences.

Amersham Biosciences, the life sciences business of Amersham plc (LSE LSE - Language Sensitive Editor , NYSE NYSE

See: New York Stock Exchange
, OSE OSE - Open Systems Environment : AHM AHM Automated Hacking Machines
AHM All Hands Meeting
AHM Academy for Healthcare Management
AHM Atom Heart Mother (Pink Floyd album)
AHM Airport Handling Manual
AHM Acutely Hazardous Material
AHM Anti-Helicopter Mine
), is a world leader in developing and providing integrated systems and solutions for disease research, drug development and manufacture. Our systems are used to uncover the function of genes and proteins, for the discovery and development of drugs and for the manufacture of biopharmaceuticals. The customers for Amersham Biosciences' products and technology are pharmaceutical and biotechnology companies and research and academic institutions, principally in North America, Europe, Latin America and Asia.

The Windber Research Institute is a free standing, working research facility, currently researching breast cancer, heart disease and prostate cancer with Walter Reed Army Medical Center in Washington, D.C.; Lifestyle Advantage and with the Preventive Medicine Research Institute in Sausalito, CA.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 19, 2001
Words:570
Previous Article:Medtronic Acquires Endonetics, Inc.
Next Article:ActiveStrategy Enhances Enterprise-Wide Application With Cognos Business Intelligence.
Topics:



Related Articles
Baker Medical Research Institute to establish core proteomics laboratory using Amersham Biosciences' technologies.
Amersham Biosciences Expands Bioprocess Capabilities Into Filtration; Acquisition of AG Technology and InnovaSep Technology.
Amersham Biosciences Selects MatrixOne to Manage Global Intellectual Capital.
Amersham Biosciences Appoints Dr. Trevor Hawkins Senior Vice President of Genomics.
Amersham Biosciences, University of Washington In Proteomics Collaboration.
Nonlinear Dynamics and Amersham Biosciences Collaborate to Automate Protein Picking From Bands in 1-D Electrophoresis Gels.
Takeda Chemical Industries, Ltd. Subscribes to Gene Logic's GeneExpress; Takeda To Access a Custom BioExpress and ToxExpress.
Amersham Biosciences Introduces Ettan DIGE Platform for 2-D Fluorescence Difference Gel Electrophoresis.
Amersham Biosciences Creates Linnaeus Chair At Muhlenberg College.
The Next Generation of Biological Scientists Can Be Found In New Jersey.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles